Historical record - last NADAC publication: 1/4/2017

Product Information

DUETACT 30-4 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $19.5115 per EA under NDC 64764030430. Its NADAC has been published 216 times since Nov 28, 2013.

DUETACT 30-4 MG TABLET

pioglitazone and glimepiride
$19.5115per EA

Strength

4; 30 mg/1; mg/1

NDC

64764030430

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/4/2017

Approval Type

New Drug (NDA)

FDA Application

NDA021925

On Market Since

7/28/2006

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Sulfonylurea Compounds
Sulfonylurea
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for DUETACT 30-4 MG TABLET has been published 216 times since Nov 28, 2013, and over the history we have for it it has risen 65.1%. The table below summarizes its recorded NADAC range and movement.

Current price$19.5115 per EA
All-time high$19.5115 (Jan 10, 2018)
All-time low$11.8158 (Nov 28, 2013)
Median price$17.2366
Average price$16.7690
Largest weekly change+9.9% (Jan 14, 2015)
Weeks tracked216
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+65.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 44%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DUETACT 30-4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DUETACT 30-4 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $19.5115 per EA (NDC 64764030430), effective Jan 10, 2018.

How has the price of DUETACT 30-4 MG TABLET changed over time?

Over the history we have for it, the NADAC for DUETACT 30-4 MG TABLET has risen 65.1%. It has been tracked across 216 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DUETACT 30-4 MG TABLET?

Since Nov 28, 2013, the NADAC for DUETACT 30-4 MG TABLET has ranged from a low of $11.8158 (Nov 28, 2013) to a high of $19.5115 (Jan 10, 2018), with a median of $17.2366 per EA.

Are there cheaper alternatives to DUETACT 30-4 MG TABLET?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PIOGLITAZONE-GLIMEPIRIDE 30-4, is $10.9734 per EA — about 44% below DUETACT 30-4 MG TABLET.

Who manufactures DUETACT 30-4 MG TABLET?

DUETACT 30-4 MG TABLET (NDC 64764030430) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.